Images (51)
दस्तावेज़
| id |
id
555645663
|
|---|---|
| contentType |
contentType
document
|
| source |
source
import
|
Source image fields (6)
Extracted text
OCR Page 1 of 51Perry D. Cohen, Ph.D.
202-686-9430 (voice/fax)
3914 Harrison St. NW
Washington, DC 20015
[email protected] (email)
January 7, 1999
Sylvin
Mr. John Podesta,
Chief of Staff
The White House
1600 Pensylvania Avenue
Washington DC
TDP
Dear Mr. Podesta:
Following our discussions with you and Chris Jennings last year, the Parkinson's community
seeks the continued support of the President. On my behalf and the Parkinson's Disease
Foundation, American Parkinson Disease Association, the National Parkinson Foundation, and
the Parkinson's Action Network, I ask that the President include language in the press release
accompanying his Fiscal Year 2000 Budget which expresses his intent to carry out the Morris K.
Udall Parkinson's Research Act (P.L. 105-78).
The Udall Act, signed into law by President Clinton on November 13, 1997, authorized up to
$100 million in Parkinson's focused research. The Parkinson's community intends to work closely
with our Congressional supporters and the NIH in the coming years to ensure that the
Congressional authorization and intent are fully implemented.
We believe that the following language [under the "Areas of Research Emphasis" or "Examples of
FY 2000 Initiatives" section] of the press release explaining the Fiscal Year 2000 Budget is
appropriate and would be effective to implement the Udall Act:
"Pursuant to the Udall Act (P.L. 105-78) and as a memorial to Congressman Morris K.
Udall, funds in the President's FY 2000 budget request include $100 million for a
heightened focus on direct Parkinson's disease research. This increased emphasis reflects
the President's conviction that the momentum from last year's gene and other discoveries
be seized and used to accelerate the transfer of new knowledge into innovative treatments
and a cure for the millions of Americans suffering from Parkinson's disease, and other
neurological disorders."
This language would complement the overwhelming bipartisan congressional support for the
Udall Act, recognize the recent major advances in Parkinson's research, and further honor the
memory of one of America's most respected political figures.
Sincerely,
Perry D. Cohen, Ph.D.
Relations
belongs_to